BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33004998)

  • 1. Clinical features and survival outcomes of ocular melanoma in a multi-ethnic Asian cohort.
    Tan LLY; Hong J; Goh WL; Chang EWY; Yang VS; Poon E; Somasundaram N; Farid M; Chan ASY; Chan JY
    Sci Rep; 2020 Oct; 10(1):16367. PubMed ID: 33004998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Patterns of Melanoma in Asians: 11-Year Experience in a Tertiary Referral Center.
    Chan KK; Chan RC; Ho RS; Chan JY
    Ann Plast Surg; 2016 Feb; 77 Suppl 1():S6-S11. PubMed ID: 26808749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.
    El Sharouni MA; Aivazian K; Witkamp AJ; Sigurdsson V; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
    JAMA Dermatol; 2021 Feb; 157(2):166-173. PubMed ID: 33355600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients.
    Sheng X; Li S; Chi Z; Si L; Cui C; Mao L; Lian B; Tang B; Wang X; Yan X; Kong Y; Dai J; Guo J
    Br J Ophthalmol; 2015 Jul; 99(7):990-6. PubMed ID: 25595173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.
    Tas F; Erturk K
    Jpn J Clin Oncol; 2021 May; 51(6):873-878. PubMed ID: 33758939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel node status predicts survival in thick melanomas: the Oxford perspective.
    Rughani MG; Swan MC; Adams TS; Marshall A; Asher R; Cassell OC; Middleton MR
    Eur J Surg Oncol; 2012 Oct; 38(10):936-42. PubMed ID: 22617251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
    Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
    Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Craniofacial resection for malignant melanoma of the skull base: report of an international collaborative study.
    Ganly I; Patel SG; Singh B; Kraus DH; Bridger PG; Cantu G; Cheesman A; De Sa G; Donald P; Fliss DM; Gullane P; Janecka I; Kamata SE; Kowalski LP; Levine PA; Medina dos Santos LR; Pradhan S; Schramm V; Snyderman C; Wei WI; Shah JP
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):73-8. PubMed ID: 16415433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test.
    Hsueh EC; DeBloom JR; Lee J; Sussman JJ; Covington KR; Middlebrook B; Johnson C; Cook RW; Slingluff CL; McMasters KM
    J Hematol Oncol; 2017 Aug; 10(1):152. PubMed ID: 28851416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.
    Munch-Petersen HD; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Sniegowski MC; Vemuganti GK; Heegaard S
    JAMA Ophthalmol; 2015 Feb; 133(2):165-73. PubMed ID: 25393033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition.
    Bajaj S; Donnelly D; Call M; Johannet P; Moran U; Polsky D; Shapiro R; Berman R; Pavlick A; Weber J; Zhong J; Osman I
    J Natl Cancer Inst; 2020 Sep; 112(9):921-928. PubMed ID: 31977051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.
    Tas F; Keskin S; Karadeniz A; Dağoğlu N; Sen F; Kilic L; Yildiz I
    Oncology; 2011; 81(5-6):353-8. PubMed ID: 22248874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased shedding of HU177 correlates with worse prognosis in primary melanoma.
    Hamilton HK; Rose AE; Christos PJ; Shapiro RL; Berman RS; Mazumdar M; Ma MW; Krich D; Liebes L; Brooks PC; Osman I
    J Transl Med; 2010 Feb; 8():19. PubMed ID: 20178639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and outcomes of melanoma in Asia: Results from the National Cancer Centre Singapore.
    Teh YL; Goh WL; Tan SH; Yong G; Sairi ANH; Soo KC; Ong J; Chia C; Tan G; Soeharno H; Tan MH; Chan M; Sathiyamoorthy S; Sittampalam K; Teh J; Chin F; Sethi V; Teo M; Quek R; Farid M
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e95-e102. PubMed ID: 29052960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.
    Aronow ME; Portell CA; Rybicki LA; Sweetenham JW; Singh AD
    Ophthalmology; 2013 Sep; 120(9):1915-9. PubMed ID: 23664470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study.
    Kim HS; Kim EK; Jun HJ; Oh SY; Park KW; Lim DH; Lee SI; Kim JH; Kim KM; Lee DH; Lee J
    BMC Cancer; 2010 Apr; 10():167. PubMed ID: 20426858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated hepatic perfusion for ocular melanoma metastasis: registry data suggests a survival benefit.
    Olofsson R; Cahlin C; All-Ericsson C; Hashimi F; Mattsson J; Rizell M; Lindnér P
    Ann Surg Oncol; 2014 Feb; 21(2):466-72. PubMed ID: 24141377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.
    Corrie PG; Marshall A; Nathan PD; Lorigan P; Gore M; Tahir S; Faust G; Kelly CG; Marples M; Danson SJ; Marshall E; Houston SJ; Board RE; Waterston AM; Nobes JP; Harries M; Kumar S; Goodman A; Dalgleish A; Martin-Clavijo A; Westwell S; Casasola R; Chao D; Maraveyas A; Patel PM; Ottensmeier CH; Farrugia D; Humphreys A; Eccles B; Young G; Barker EO; Harman C; Weiss M; Myers KA; Chhabra A; Rodwell SH; Dunn JA; Middleton MR; ; Nathan P; Lorigan P; Dziewulski P; Holikova S; Panwar U; Tahir S; Faust G; Thomas A; Corrie P; Sirohi B; Kelly C; Middleton M; Marples M; Danson S; Lester J; Marshall E; Ajaz M; Houston S; Board R; Eaton D; Waterston A; Nobes J; Loo S; Gray G; Stubbings H; Gore M; Harries M; Kumar S; Goodman A; Dalgleish A; Martin-Clavijo A; Marsden J; Westwell S; Casasola R; Chao D; Maraveyas A; Marshall E; Patel P; Ottensmeier C; Farrugia D; Humphreys A; Eccles B; Dega R; Herbert C; Price C; Brunt M; Scott-Brown M; Hamilton J; Hayward RL; Smyth J; Woodings P; Nayak N; Burrows L; Wolstenholme V; Wagstaff J; Nicolson M; Wilson A; Barlow C; Scrase C; Podd T; Gonzalez M; Stewart J; Highley M; Wolstenholme V; Grumett S; Goodman A; Talbot T; Nathan K; Coltart R; Gee B; Gore M; Farrugia D; Martin-Clavijo A; Marsden J; Price C; Farrugia D; Nathan K; Coltart R; Nathan K; Coltart R
    Ann Oncol; 2018 Aug; 29(8):1843-1852. PubMed ID: 30010756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
    Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
    Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
    Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.